Olaparib

Drug / Medication

A targeted drug for pancreas cancer patients with germline BRCA mutations; in the POLO trial, it showed progression-free survival benefit but no overall survival benefit when compared to sugar pill, leading to questions about its real efficacy and high cost.

Mentioned in 1 video

Videos Mentioning Olaparib

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Peter Attia MD

A targeted drug for pancreas cancer patients with germline BRCA mutations; in the POLO trial, it showed progression-free survival benefit but no overall survival benefit when compared to sugar pill, leading to questions about its real efficacy and high cost.